These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39095792)

  • 1. New concept in selecting blue dye injection site effect on clinical outcome of early-stage breast cancer patients: a retrospective cohort.
    Bongkodmas P; Vacharathit V; Lerttiendamrong B; Manasnayakorn S; Tantiphlachiva K; Vongwattanakit P; Treeratanapun N; Vongsaisuwon M
    World J Surg Oncol; 2024 Aug; 22(1):207. PubMed ID: 39095792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
    Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
    J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
    Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
    Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
    Simmons R; Thevarajah S; Brennan MB; Christos P; Osborne M
    Ann Surg Oncol; 2003 Apr; 10(3):242-7. PubMed ID: 12679308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
    Kavallaris A; Camara O; Runnebaum IB
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
    Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
    Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
    Tsunoda N; Iwata H; Sarumaru S; Mizutani M; Iwase T; Miura S
    Breast Cancer; 2002; 9(4):323-8. PubMed ID: 12459714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.
    Bauer TW; Spitz FR; Callans LS; Alavi A; Mick R; Weinstein SP; Bedrosian I; Fraker DL; Bauer TL; Czerniecki BJ
    Ann Surg Oncol; 2002 Mar; 9(2):169-76. PubMed ID: 11888875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
    Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
    Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up results of breast cancer patients with sentinel lymph node biopsy using periareolar injection.
    Imasato M; Shimazu K; Tamaki Y; Taguchi T; Tanji Y; Kim SJ; Noguchi S
    Am J Surg; 2010 Apr; 199(4):442-6. PubMed ID: 19596117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
    Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
    Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
    Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
    Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.